CIP
ABBV icon

Cornerstone Investment Partners’s AbbVie ABBV Stock Holding History

Cornerstone Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,509
Closed -$1.05M – 202
2022
Q4 		$1.05M Hold
6,509
– – 0.07% 52
2022
Q3 		$874K Hold
6,509
– – 0.06% 52
2022
Q2 		$997K Sell
6,509
-6,498
-50% -$993K 0.07% 51
2022
Q1 		$2.11M Sell
13,007
-3,690
-22% -$536K 0.12% 33
2021
Q4 		$2.26M Sell
16,697
-5,460
-25% -$645K 0.13% 33
2021
Q3 		$2.39M Sell
22,157
-1,110
-5% -$127K 0.14% 36
2021
Q2 		$2.62M Hold
23,267
– – 0.14% 37
2021
Q1 		$2.52M Buy
23,267
+1,460
+7% +$156K 0.14% 38
2020
Q4 		$2.34M Hold
21,807
– – 0.14% 37
2020
Q3 		$1.91M Buy
21,807
+2,000
+10% +$188K 0.13% 42
2020
Q2 		$1.95M Sell
19,807
-3,723
-16% -$328K 0.14% 42
2020
Q1 		$1.79M Buy
23,530
+1,240
+6% +$106K 0.12% 45
2019
Q4 		$1.97M Hold
22,290
– – 0.09% 46
2019
Q3 		$1.69M Hold
22,290
– – 0.07% 45
2019
Q2 		$1.62M Buy
22,290
+2,575
+13% +$202K 0.07% 46
2019
Q1 		$1.59M Buy
19,715
+1,410
+8% +$115K 0.07% 45
2018
Q4 		$1.69M Buy
18,305
+1,665
+10% +$146K 0.08% 41
2018
Q3 		$1.57M Hold
16,640
– – 0.07% 43
2018
Q2 		$1.54M Hold
16,640
– – 0.07% 40
2018
Q1 		$1.57M Buy
16,640
+905
+6% +$99.4K 0.07% 41
2017
Q4 		$1.52M Hold
15,735
– – 0.07% 43
2017
Q3 		$1.4M Buy
15,735
+1,300
+9% +$99K 0.06% 40
2017
Q2 		$1.05M Buy
14,435
+3,965
+38% +$267K 0.05% 53
2017
Q1 		$682K Buy
+10,470
New +$658K 0.03% 63

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cornerstone Investment Partners's ABBV Position: Q1 2023 in Review

Cornerstone Investment Partners sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 6,509 shares — an estimated $1.05M sold.

Cornerstone Investment Partners first reported a position in ABBV in Q1 2017 and held it in 24 quarters. The position peaked at $2.62M in Q2 2021. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

  • Cornerstone Investment Partners reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
  • Cornerstone Investment Partners sold 6,509 AbbVie shares in Q1 2023, an estimated $1.05M.
  • Cornerstone Investment Partners first reported a position in AbbVie in Q1 2017 and held it in 24 quarters.
  • Cornerstone Investment Partners's AbbVie position peaked at $2.62M in Q2 2021.
  • 3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Cornerstone Investment Partners's 13F filing for Q1 2023, filed 21 Apr 2023.